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Abstract
Patients with insulin-dependent diabetes (IDDM) possess anti-
bodies to islet proteins of M,-64,000. Potential autoantigens of
this Mr include glutamate decarboxylase (GAD) and 65 kD
heat shock protein. We have detected two distinct antibody
specificities in IDDM that bind 50,000 M, or 37,000/40,000
M, proteolytic fragments of 64,000 M, proteins. In this study,
we investigated relationships of these proteolytic fragments to
GAD and heat shock proteins. Polyclonal antibodies to GAD
bound 50,000 M, fragments of islet antigen. Recombinant
GAD65, but not GAD67, blocked binding to this antigen, sug-
gesting that 50,000 M, fragments are derived from islet
GAD65. In contrast, GAD antibodies did not recognize 37,000/
40,000 M, fragments, and neither GAD isoforms blocked au-
toantibody binding to precursors of these fragments. The
37,000/40,000 M, fragments, but not the 50,000 M, frag-
ments, were detected after trypsin treatment of immunoprecipi-
tates from insulinoma cells that lacked expression of major
GAD isoforms. Antibodies in IDDM did not bind native or
trypsinized islet heat shock proteins. Thus, IDDM patients
possess antibodies to GAD, but also distinct antibodies to a
64,000 M, protein that is not related to known GAD isoforms
or heat -shock proteins. (J. Clin. Invest. 1993. 92:240-248.)
Key words: insulin-dependent diabetes * glutamate decarboxyl-
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Introduction
It is generally accepted that the specific destruction of pancre-
atic beta cells in insulin-dependent diabetes mellitus (IDDM)'
is the result of an autoimmune response against one or more
components of these cells (1). Studies to characterize islet cell
autoantigens associated with IDDM have identified one or
more proteins ofMr-64,000 that are specifically immunoprecip-
itated by antibodies in sera from IDDM patients (2-4). These
proteins can associate with membranes and have amphiphilic
properties, partitioning into a detergent phase on phase separa-
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tion in Triton X- 114 (5). The y-aminobutyric acid-synthesiz-
ing enzyme, glutamic acid decarboxylase (GAD) has been
identified as a major 64,000 M, autoantigen in IDDM (6).
GAD exists as multiple isoforms with different tissue-specific
patterns of expression, membrane association, and reactivity
with antibodies in diabetes (7-10). Two isoforms of GAD
(GAD65 and GAD67) have been cloned and sequenced (9, 11),
and both isoforms are expressed in brain and islets (7, 8).
GAD65 has similar membrane-binding properties to islet anti-
gen (8), and recombinant GAD65 has been shown to compete
for autoantibody binding to islet 64,000 M, protein, suggesting
that the lower molecular weight isoform is related to the islet
antigen (12).
By studying antibody binding to proteolytic fragments, we
have identified two distinct antibody specificities to 64,000 Mr
proteins in sera from IDDM patients (13). Partial tryptic pro-
teolysis of antigens immunoprecipitated from detergent ex-
tracts of islets generates three major fragments of Mr 50,000,
40,000, and 37,000. Diabetic patients possess antibodies to
50,000 M, fragments, and distinct antibodies that recognize
both 40,000 M, and 37,000 M, fragments of antigen. Antibod-
ies that bind the 50,000 Mr fragment (50k antibodies) also
immunoprecipitate GAD from islet and brain extracts,
whereas antibodies that bind 37,000 Mr and 40,000 M, frag-
ments (37k antibodies) do not recognizeGAD (10). These 37k
antibodies may recognize hidden determinants on GAD that
are only exposed on trypsin cleavage, or may be directed to a
protein distinct from GAD (10).
We have previously suggested that the 50k- and 37k-anti-
body specificities recognize determinants on different 64,000
Mr proteins (13). Alternative candidate antigens in IDDM in-
clude a 65-kD heat shock protein (hsp 65). Both antibody and
T cell reactivity to heat shock protein (hsp) 65 have been de-
tected in the nonobese diabetic mouse model of IDDM (14,
15) and hsp 65 has been suggested to be a target for autoanti-
bodies in human IDDM ( 16 ). However, analysis ofbinding of
antibodies in IDDM patients' sera to proteins in extracts of
islets exposed to heat shock has failed to provide evidence for
antibodies to islet heat shock proteins in the human disease
( 17). The aim of this study was to clarify whether the 50,000
Mr, 40,000 Mr, and 37,000 Mr fragments of islet antigen are
derived from distinct proteins and to investigate the relation-
ships of these fragments to GAD and heat shock proteins.
Methods
Sera and antibodies. Sera from recent onset IDDM patients, obtained
within 10 d of diagnosis of disease, or from normal healthy controls,
were selected from previous studies on antibodies to islet cell antigens
( 10, 13, 18). Serawere previously characterized forpresence ofantibod-
ies to islet 64,000 Mr proteins ( 18), to rat brain GAD ( 10), and to
tryptic fragments of islet antigen ( 13 ). Specific antibodies to GAD and
heat shock proteins were also used in antigen characterization. These
240 Christie, Hollands, Brown, Michelsen, and Delovitch
J. Clin. Invest.
© The American Society for Clinical Investigation, Inc.
0021-9738/93/07/240/09 $2.00
Volume 92, July 1993, 240-248
Downloaded from http://www.jci.org on August  7, 2015.   http://dx.doi.org/10.1172/JCI116556
included a polyclonal sheep antiserum to purified rat brain GAD ( 19),
a rabbit antibody ( 1266) to a COOH-terminal 19-amino acid peptide
ofGAD67 ([9 ], gift of Dr. J. Petersen, Hagedorn Research Laboratory,
Gentofte, Denmark), a rabbit antibody (5551) to a 14-amino acid
peptide (VTWNPHKMMGVPLQ) spanning the pyridoxal phosphate
binding site ofGAD65 (gift of Prof. A. Lernmark, University ofWash-
ington, Seattle, WA) and a rabbit antiserum to Gro EL protein of
Escherichia coli ([20], gift of Dr. S. Hemmingsen, Plant Biology Insti-
tute, National Research Council, Saskatoon, Canada), which cross-
reacts with mammalian heat shock proteins hsp 65 and hsp 70. Normal
sheep serum and normal rabbit serum (Sigma Immunochemicals, St.
Louis, MO) were used as controls for these antibodies.
Islet and insulinoma cellpreparations. Islets from 5-7-d-old neona-
tal Wistar rats were prepared as previously described (21 ). SV40-trans-
formed hamster insulinoma cells (HIT-T1 5, gift of Dr. S. J. H. Ash-
croft, University ofOxford, UK) and radiation-induced rat insulinoma
cells (subclone RIN-SAH, gift ofDr. A. Lernmark, University ofWash-
ington, Seattle, WA) were maintained in tissue culture in RPMI 1640
medium containing 10% fetal calf serum. Islet and insulinoma cell
proteins were radiolabeled with [35S] methionine (Amersham Interna-
tional, Buckinghamshire, UK) for 5 h at 370C as described (3).
Heat shock treatment of pancreatic islets. In some experiments,
islets were subjected to heat shock prior to labeling with [35S]-
methionine. After an overnight period in tissue culture, batches of
2000-3000 islets were incubated at 370C (control) or 440C (heat
shock) for 20 min in 1 ml of RPMI 1640 medium containing 20 mM
Hepes (pH 7.4), 5 mM NaHCO3, 2 mg/ml bovine serum albumin
(labeling medium) before labeling with [35S]methionine as de-
scribed (3).
Expression ofrecombinant GAD. COS-7 fibroblast cells were trans-
fected with cDNA for rat islet GAD67 and endogenous proteins labeled
with [35S]methionine as previously described (9). BHK cells were
transfected with cDNA for human GAD65 and GAD67 (22) and main-
tained as stable cell lines, 64/11 and K87-8, respectively.
Cellular extraction and immunoprecipitation. Radiolabeled islets
(2000-4000), insulinoma cells (2.5 x 107 cells) or COS cell transfec-
tants were homogenized on ice by 20 passes ofa motor-driven Teflon/
glass homogenizer (Wheaton Instruments, Millville, NJ) in 600 Al of
0.25 M sucrose, 10mM Hepes (pH 7.4), 10mM benzamidine, 0.1 mM
p-chloromercuribenzene sulphonic acid, and 0.5% (wt/ vol) aprotinin.
The homogenate was centrifuged at 10,000 g for 30 min at 4°C. The
supernatant (Sl fraction) was collected and the pellet processed for
phase separation in the detergent Triton X-1 14 or for trypsinization at
0.5 mg/ml trypsin (type XIII; Sigma Immunochemicals) as previously
described (5, 13).
Before immunoprecipitation, Triton X-1 14 extracts, SI fractions,
or trypsin extracts were precleared with 50 ,l of normal human serum
for 2 h at 4°C followed by binding to 100 Ml of protein A Sepharose
(Sigma Immunochemicals) for 45 min at 4°C. A second preclearance
was performed with 50 Ml of normal human serum for 18 h at 4°C and
100 Ml ofprotein A Sepharose for 45 min. Aliquots ofextract represent-
ing 5 X 106 cpm of radiolabeled protein in 50 Ml were incubated with
12.5 Ml ofserum from type 1 diabetic patients or control individuals, or
2 Ml of sheep or rabbit serum containing high titers of specific antibod-
ies, for 5 h at 4°C. In competition experiments, Triton X-1 14 extracts
ofBHK cells transfected with GAD cDNA were added to radiolabeled
islet extracts before incubation with sera. Immune complexes were iso-
lated on 25 Ml (human sera) or 10 Ml (rabbit and sheep sera) of protein
A Sepharose processed for SDS-PAGE on 12% polyacrylamide gels and
for autoradiography as previously described (3). In some experiments,
immune complexes isolated on protein A Sepharose were incubated
with 100 Ml of 0.1 mg/ml trypsin in 10mM Hepes, 150 mM NaCl for
20 min at 4°C and washed with 1 ml of water before SDS-PAGE.
Where indicated, urea (8 M) was included in the sample buffer for
SDS-PAGE.
Immunoprecipitation ofglutamate decarboxylase and trypticfrag-
mentsfrom tissue extracts. Tissue contents ofGAD, and the ability of
antibodies in patients' sera to immunoprecipitate GAD enzyme activ-
ity from brain, islets, or insulinoma cell extracts, were measured as
previously described (10).
The ability of sera to recognize GAD immunoreactivity, or tryptic
fragments of GAD, from rat brain was analyzed by Western blotting.
Soluble extracts of brain containing intact GAD were prepared as de-
scribed ( 10). Trypsin extracts ofbrain were prepared by homogenizing
brains from two Wistar rats in 5 ml of 0.25 M sucrose, 10 mM Hepes
(pH 7.4), 10 mM benzamidine, 0.1 mM p-chloro mercuribenzene
sulphonic acid, 5 mM phenylmethylsulfonyl fluoride and particulate
material sedimented at 10,000 g for 30 min. Pellets were washed once
in 3 ml of 10 mM Hepes (pH 7.4), 150 mM NaCl, 10 mM benzami-
dine, 5 mM phenylmethylsulfonyl fluoride and twice in 3 ml of 10mM
Hepes (pH 7.4), 150 mM NaCl. Pellets were extracted in 12 ml of 10
mM Hepes (pH 7.4), 150mM NaCl, 0.5 mg/ml trypsin for 30 min on
ice and the reaction stopped by the addition of phenylmethylsulfonyl
fluoride to 5 mM. Nonextracted material was removed by centrifuga-
tion at 10,000 g for 15 min.
Soluble brain extracts or trypsin extracts of brain (50-Ml aliquots)
were incubated with 12.5 Ml of serum for 5 h at 4°C. Immune com-
plexes were isolated on protein A Sepharose, and washed and processed
for SDS-PAGE as previously described (3). Separated proteins were
transferred electrophoretically to nitrocellulose (23) and nitrocellulose
blots incubated with a 1:1000 dilution of rabbit antisera to GAD pep-
tides. Antibody binding to proteins on nitrocellulose was visualized
with an alkaline phosphatase-conjugated second antibody to rabbit IgG
(Sigma Immunochemicals) with nitroblue tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate as substrate.
Two-dimensional gel electrophoresis. Islet extracts were processed
for two-dimensional gel electrophoresis, with isoelectric focusing in the
first dimension and SDS-PAGE in the second dimension, by the
method of Hochstrasser et al. (24).
Protein content and protein synthesis. Protein contents of tissue
homogenates were determined by the Biuret reaction (25). [35S]-
methionine incorporation into proteins was determined by spotting
5-,Ml aliquots of tissue homogenates onto filter papers and precipitating
proteins in ice-cold 10% trichloroacetic acid. Filter papers were washed
extensively in 10% trichloroacetic acid and subsequently in ethanol,
dried, and radioactivity incorporated into precipitated material deter-
mined by scintillation counting.
Results
Binding ofantibodies to islet and brain antigens. During our
studies on autoantibody binding to proteins in detergent ex-
tracts of islets, we observed that some IDDM patients who
lacked antibodies to GAD were still able to immunoprecipitate
proteins of Mr 64,000 (Fig. 1 a, lane 1). These proteins were
resolved as a diffuse doublet on SDS-PAGE and appeared dis-
tinct from the dominant 64,000 Mr protein immunoprecipi-
tated by sera containing GAD antibodies (Fig. 1 a, lane 2).
Analysis of antibody binding to tryptic fragments of islet anti-
gen indicated that these GAD-antibody-negative patients
lacked antibodies to 50,000 Mr fragments but possessed anti-
bodies that recognized 37,000 and 40,000 Mr fragments (Fig. 1
b, lane 1). Sera from patients positive for GAD antibodies
immunoprecipitated 50,000 M, fragments from trypsin ex-
tracts of islets (Fig. 1 b, lane 2). These observations led us to
investigate whether IDDM is associated with antibodies to
64,000 Mr proteins that are distinct from GAD.
We determined whether the different fragments of islet an-
tigen were recognized by a polyclonal sheep antiserum to rat
brain GAD. Fig. 2 a illustrates polypeptides immunoprecipi-
tated from trypsin extracts of islets by antibodies in diabetic
patients' sera or by the antiserum to GAD. Diabetic patients
were identified with antibodies to the 50,000 Mr fragment of
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Figure 1. Autoantibody recognition of islet antigens. Sera from a
GAD-antibody-negative IDDM patient (lanes 1), a
GAD-antibody-positive patient (lanes 2) and a control subject (lanes
3) were used to immunoprecipitate proteins from detergent extracts
(a) or trypsin extracts (b) of rat islets. Polypeptides immunoprecipi-
tated were detected by SDS-PAGE and autoradiography. The Mrs of
major polypeptides recognized by antibodies are marked.
antigen (Fig. 2 a, lane 1), antibodies to 37,000 and 40,000 Mr
fragments of antigen (Fig. 2 a, lane 2) and antibodies to all
three fragments (Fig. 2 a, lane 3). These fragments were not
recognized by control sera (Fig. 2 a, lane 4). The antiserum to
GAD immunoprecipitated only 50,000 Mr fragments and
failed to recognize either 40,000 or 37,000 Mr fragments from
the islet trypsin extract (Fig. 2 a, lane 5).
To further characterize relationships of the antigenic frag-
ments to GAD, patients' sera were tested for their ability to
immunoprecipitate GAD immunoreactivity from soluble or
trypsin-treated rat brain extracts. Immunoprecipitated GAD
polypeptides were visualized by Western blotting using an anti-
body raised to a COOH-terminal peptide of GAD67, which
cross-reacts withGAD65 (9) . Serum from diabetic patients posi-
tive for antibodies to islet 50,000 Mr tryptic fragments also
immunoprecipitated 64,000Mr proteins withGAD immunore-
activity from soluble brain extracts (Fig. 2 b, lanes I and 3),
and 50,000 Mr tryptic fragments from trypsin extracts ofbrain
(Fig. 2 c, lanes I and 3). Sera containing only 37 k antibodies
did not immunoprecipitateGAD immunoreactivity from solu-
ble or trypsin extracts ofbrain (Fig. 2 b, lane 2; Fig. 2 c, lane 2).
Identical results were obtained in Western blotting experi-
ments using an antibody raised to a peptide spanning the pyri-
doxal phosphate binding site of GAD65 (data not shown).
Thus, trypsin extracts of brain contain 50,000 M, fragments
that are immunoprecipitated by antibodies in diabetic patients'
sera and that bear determinants for antibodies raised to two
distinct GAD peptides. Trypsinization ofbrain does not gener-
ate 40,000 and 37,000 Mr fragments recognized by these GAD
antibodies.
The same sera were characterized for their ability to im-
munoprecipitate GAD67, or trypsin-treated GAD67, from ex-
tracts of COS fibroblasts transfected with rat islet GAD67
cDNA. Only one of the diabetic patients immunoprecipitated
a 67,000 Mr protein from Triton X-l 14 extracts of COS cell
transfectants (Fig. 2 d, lane 1) that comigrated with a 67,000
M, protein immunoprecipitated by the sheep antiserum to
GAD (Fig. 2 dlane 5). The 37k-antibody-positive sera did not
immunoprecipitate GAD67 (Fig. 2 d, lanes 2 and 3). In an
a. Islet
trypsin extract
1 2 3 4 5 6
b. Brain
Sl fraction
1 2 3 4
c. Brain d. GAD-67 e. GAD-67 COS
trypsin extract COS extract
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Figure 2. Immunoprecipitation of antigens in IDDM. Sera from IDDM patients (lanes 1-3), a healthy control subject (lanes 4), a sheep anti-
serum to rat brain GAD (lanes 5) or normal sheep serum (lanes 6) were used to detect antigens in various cell extracts. Sera were incubated
with trypsin extracts [35S]methionine-labeled rat islets (a), cytosolic (Sl ) fractions of brain (b), trypsin extracts of brain (c), detergent extracts
of COS cells transfected with cDNA for GAD67 (d), and trypsin extracts ofCOS cells transfected with GAD67 (e). Immune complexes were
isolated on protein A Sepharose and separated by SDS-PAGE. In a, d and e, immunoprecipitated polypeptides were identified by autoradiogra-
phy; in b and c by Western blotting with an antibody to a COOH-terminal peptide ofGAD. The Mrs (X lO-3) ofmajor polypeptides recognized
by antibodies are marked. The broad band in b and c (Ig) is immunoglobulin heavy chain that binds the alkaline phosphatase-conjugated second
antibody.
242 Christie, Hollands, Brown, Michelsen, and Delovitch
a. Detergent extract
1 2 3
-t-i,
64k o X ;
*:.^ ;. .i
64 --w
50 - , *WiS
40-Ill
37 w
' 67
-o-- 57
4 Ig
Downloaded from http://www.jci.org on August  7, 2015.   http://dx.doi.org/10.1172/JCI116556
analysis of antibodies in 16 recent onset IDDM patients, 9
(62.5%) had antibodies that immunoprecipitated recombinant
GAD67. No significant correlation was observed between the
ability to immunoprecipitate GAD67 from COS cell transfec-
tants and GAD enzyme activity from rat brain extracts (r
= 0.477, P > 0.05; Spearman correlation) or 37,000 Mr tryptic
fragments from islet extracts (r = 0.013, P > 0.5). Diabetic
patients positive for antibodies to GAD67, and the sheep anti-
serum to GAD, also immunoprecipitated polypeptides of
- 57,000 Mr from trypsin extracts of the COS cell transfec-
tants (Fig. 2 e, lanes I and 5).
Studies were performed to determine whether recombinant
human GAD65 orGAD67 can compete for binding with autoan-
tibodies to rat islet antigens. Triton X- 114 extracts of BHK
cells containing the recombinant proteins were added to deter-
gent phase extracts of [35S ] methionine-labeled islets before im-
munoprecipitation with diabetic patient's serum. Immunopre-
cipitates were treated with trypsin before gel electrophoresis to
distinguish antibody binding to 50,000 Mr fragment-related
and 37,000/40,000 M, fragment-related antigens. Addition of
GAD65, but not GAD67, blocked binding of antibodies to pro-
teins generating 50,000 Mr fragments on trypsinization (Fig.
3). GAD67 was ineffective even with sera strongly positive for
antibodies to recombinant GAD67 (Fig. 3, patient 2). Addition
of the recombinant proteins had no effect on antibody binding
to protein precursors of 40,000 and 37,000 M, fragments.
GAD and autoantigen expression in insulinoma cells. Anal-
ysis of antigen binding to antibodies in diabetic patients was
extended to two transformed insulin-secreting cell lines, HIT-
T 15 and RIN-SAH. GAD enzyme activity was detected in ho-
mogenates of both of these cell lines, at activities of 2.28±0.28
ptmol/16 h per g protein (n = 3) for HIT-T15 cells and
50 ->-
3.04±0.53 Aimol / 16 h per g protein (n = 3) for RIN-5AH cells.
In parallel experimentsGAD enzyme activities in rat brain and
neonatal rat islets were 104.26 and 9.52 ztmol/ 16 h per g pro-
tein, respectively ( 10 ). Sera from three diabetic patients deter-
mined to be strongly positive for antibodies to 50,000 M, frag-
ments of antigen immunoprecipitated GAD enzyme activity
from islet and brain extracts (Fig. 4). In contrast, the GAD
activities in HIT-T 15 and RIN-5AH cell extracts, adjusted to
similar enzyme concentrations as those in islet and brain prepa-
rations, were not recognized by antibodies in the diabetic pa-
tients' sera (Fig. 4). In Western blot studies, antibodies to
GAD peptides did not recognize 64,000 or 67,000 Mr polypep-
tides in extracts of RIN-5AH or HIT-T 15 cells (data not
shown). Thus, GAD enzyme activity can be detected in insu-
linoma cell lines, but this activity is immunochemically dis-
tinct from the major isoforms ofGAD expressed in brain and
islets.
The ability ofantibodies to recognize polypeptides in deter-
gent extracts of radiolabeled insulinoma cells was analyzed.
Antibodies in sera from 37k-antibody-positive IDDM patients
specifically immunoprecipitated a 64,000 M, protein from de-
tergent phase purified extracts of RIN-5AH cells, detectable
only when immune complexes were solubilized in the presence
of 8 M urea (Fig. 5). Trypsinization of the immunoprecipi-
tated protein before electrophoresis generated 37,000 and
40,000 Mr fragments, but not 50,000 Mr fragments (Fig. 5).
Similar results were obtained with HIT-T 15 cells.
Competition experiments were performed to determine
3-
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Figure 3. Blocking of antibody binding to islet antigens with recom-
binant GAD. Triton X-l 14 detergent phase extracts of [I'S]-
methionine-labeled rat islets were incubated with IDDM patients' sera
in the presence ofTriton X- 1 14 extracts from (a) untransfected BHK
cells (extract from 3.3 x IO' cells) (b) BHK cell line (64/11 ) trans-
fected with cDNA for GAD65 (3.3 x 104 cells containing 7.2 nmol/2
h GAD), or (c) BHK cell line (87-1 1) transfected with cDNA for
GAD67 (2 x lO cells containing 2.0 nmol/2 h GAD). Immune
complexes were isolated on protein A Sepharose and treated with
trypsin (0.1 mg/ml) before SDS-PAGE. All patients were positive
for antibodies to GAD from rat brain; patient 2 was strongly positive
for antibodies to recombinant GAD67 (patient 1 in Fig. 2).
Figure 4. Immunoprecipitation of GAD activity from islets, brain,
and insulinoma cell extracts. Nonidet P40 detergent-solubilized ex-
tracts (50 pi aliquots) of rat islets, rat brain, RIN-5AH cells, or HIT-
T15 cells were incubated with sera from IDDM patients (first four
bars for each tissue) and a normal control serum (fifth bar). Patients
represented by bars 1-3 were positive for 50k antibodies and those
represented by bars 2-4 were positive for 37k antibodies. The mean
(±SEM) GAD activities in tissue extracts were 1.06±0.22 (islets),
2.19±0.37 (brain), 0.68±0.25 (RIN cells) and 3.58±0.40 (HIT cells)
nmol/ 16 h per 50 ,ul (n = 3). GAD activity in immunoprecipitates
for each serum is shown. The results are mean±SEM of 3 indepen-
dent observations.
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Figure 5. Immunoprecipitation of antigens from RIN-5AH insulinoma cells. Triton X- 1 14 detergent phase extracts of RIN-5AH cells were in-
cubated with serum from IDDM patients (lanes 1-5) or control subjects (lanes 6 and 7). Immune complexes were isolated on protein A Seph-
arose and either eluted in SDS sample buffer containing 8 M urea (left panel) or treated with trypsin (0.1 mg/ml) before elution in sample buffer
(right panel). Polypeptides were separated by SDS-PAGE and detected by autoradiography. The M~s(X 0 -3) of polypeptides immunoprecipi-
tated by antibodies in IDDM patient's serum are marked.
whether insulinoma cell antigen can compete for autoantibody
binding to fragments of islet antigen. Addition of trypsin ex-
tracts of unlabeled HIT-T1 5 cells blocked immunoprecipita-
tion of 37,000 and 40,000 M, fragments from [35S]_
methionine-labeled islet extracts but did not affect binding to
50,000 Mr fragments. The insulinoma cells, therefore, contain
proteins with similar antigenic properties to 37,000 Mr and
40,000 Mr islet fragments, but may lack proteins from which
50,000 M, fragments are derived.
Binding ofantibodies to islet proteins after heat shock treat-
ment. To investigate possible relationships of islet 64,000 Mr
autoantigens to heat shock proteins, antibody reactivity to in-
tact and trypsin-treated islet antigens was investigated in islets
exposed to heat shock. Islets were incubated at 37°C (control)
or 44°C (heat shock) for 20 min before labeling islet proteins
with [3S]methionine. Incorporation of [35S] methionine into
trichloroacetic acid-precipitable protein in heat shock treated
islets was 93.7±2.96% (mean±SEM, n = 4) of the incorpora-
tion at 37°C. Two-dimensional gel electrophoresis ofislet pro-
teins revealed considerable increases in the intensities of pro-
teins of Mr 110,000, 90,000, 70,000, and 62,000 after heat
shock (Fig. 6). Incorporation of label into most other individ-
ual proteins was similar under control and heat shock condi-
tions.
The greater proportion ofproteins stimulated by heat shock
were recovered in the supernatant (S 1 ) fraction after centrifuga-
tion of islet homogenates. Immunoprecipitation experiments
with SI fractions were performed to determine the ability of
antibodies to recognize proteins induced by heat shock. A poly-
clonal rabbit antibody to Gro EL protein, the E. coli homo-
logue ofhsp 65, immunoprecipitated 62,000 Mr and 70,000 Mr
islet proteins stimulated by heat shock treatment (Fig. 7). The
62,000 Mr hsp was not immunoprecipitated by antibodies in
serum from a recent onset IDDM patient; similar results were
obtained with five other IDDM patients. In experiments with
extracts from heat shock-treated islets, 70,000 M, hsp was asso-
ciated with immunoprecipitates with all control and diabetic
sera tested. Similar nonspecific binding of hsp 70 to immune
complexes has been observed in other immunoprecipitation
studies (26). A 67,000 Mr protein was immunoprecipitated
from Sl fractions of islets incubated at 37°C by antibodies in 3
of the 6 IDDM patients' sera tested, but not from extracts of
heat shock-treated islets (Fig. 7).
Detergent phase fractions from islets preincubated at 37°C
or 44°C were used in immunoprecipitation experiments to de-
termine the effect ofheat shock on islet antigen expression. The
64,000 Mr antigen migrated at a slightly higher Mr than the
62,000 Mr hsp (Fig. 7). The recovery ofradiolabeled 64,000 Mr
antigen was reduced in experiments with detergent phase ex-
tracts of islets preincubated at 44°C.
Trypsin solubilized extracts of islet particulate proteins
were used to compare expression of precursors of antigenic
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Figure 6. Islet protein expression after heat shock. Islets preincubated for 20 min at 370C or 440C were labeled with [35S]methionine for 5 h.
Proteins in cytosolic (SI ) fractions were separated by isoelectric focusing (IEF, first dimension) and SDS-PAGE (second dimension) and radio-
labeled proteins detected by autoradiography. The Mrs (X 10-3) of major proteins where [35S] methionine incorporation was stimulated by heat
shock is indicated.
tryptic fragments after heat shock. The recovery of immuno- was relatively unchanged (Fig. 7). Densitometric scanning of
precipitable 50,000 Mr fragment of antigen was reduced after bands on autoradiograms representing immunoprecipitated
heat shock, whereas recovery of 37,000 M, tryptic fragment polypeptides indicated a reduction in 50,000 M, fragment after
SI fraction
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Figure 7. Effect of heat shock on islet antigen expression. Cytosolic (S1) fractions, detergent phase fractions or trypsin extracts of islets incubated
at 370C or 440C before labeling with [35S]methionine were incubated with rabbit antibody to Gro EL protein (lanes a), serum from a healthy
control individual (lanes b) and serum from an IDDM patient (lanes c). Immunoprecipitated proteins were identified by SDS-PAGE and auto-
radiography. The Mrs ( x l0-I) of major proteins stimulated by heat shock are marked on left of figure and tryptic polypeptides recognized by
antibodies in IDDM on right of figure. The arrowheads indicate the 67,000 Mr protein in S I fraction, and 64,000 Mr protein in detergent phase
fraction, immunoprecipitated by antibodies in IDDM.
A utoantigens in Insulin-dependent Diabetes 245
I I,."
37'0C
sDS-
PAGsE
i-4
-4 .
.
. .I*
.4--
Df4
.:. v At' .,..
AM,7w,
,ft.4 0 `.-
Downloaded from http://www.jci.org on August  7, 2015.   http://dx.doi.org/10.1172/JCI116556
heat shock to 9.59±1.50% (mean±SEM) ofthat under control
conditions, whereas the density of 37,000 Mr bands was
89.9±10.7% of control conditions (n = 4; P < 0.01, paired t
test).
Discussion
We have previously shown that mild trypsin digestion of islet
proteins immunoprecipitated by antibodies in IDDM gener-
ates three major fragments of M, 50,000, 40,000, and 37,000
( 13 ). By analyzing antibody reactivity to these fragments, we
have detected antibodies in sera from IDDM patients that rec-
ognize 50,000 Mr fragments and distinct antibodies that recog-
nize common determinants on the 40,000 and 37,000 Mr frag-
ments. We have speculated that these fragments are derived
from more than one 64,000 M, protein ( 13). GAD has been
identified as a major 64,000 Mr antigen (6); other authors have
suggested that heat shock proteins might be antigens in IDDM
( 14-16). In this study, we have determined whether these frag-
ments are indeed derived from distinct proteins and have in-
vestigated possible relationships between the fragments of islet
antigen, GAD, and heat shock proteins.
There is strong evidence that the 50,000 Mr component is
derived from GAD. We have previously observed a high degree
of correlation between the ability ofantibodies to immunopre-
cipitate a GAD enzyme activity from rat brain extracts and the
ability ofantibodies to bind 50,000 Mr tryptic fragments ofislet
antigen ( 10). In this study, a polyclonal sheep antiserum raised
to brain GAD immunoprecipitated 50,000 Mr tryptic frag-
ments that comigrated on SDS-PAGE with 50,000 Mr frag-
ments recognized by antibodies in IDDM. Furthermore, sera
containing antibodies to 50,000 Mr fragments of islet antigen
also immunoprecipitated fragments of identical size from tryp-
sin extracts ofbrain that were recognized by antibodies toGAD
peptides. In a study by Baekkeskov et al. (6), trypsin treatment
was shown to generate 55,000 Mr immunoreactive fragments
from both islet and brain GAD, and these 55,000 Mr polypep-
tides may be equivalent to the 50,000 M, fragments observed in
our study. These data suggest that the 50,000 Mr component of
antigen is a tryptic polypeptide of GAD that includes the
COOH-terminal domain of the enzyme. Addition of recombi-
nant GAD65 blocked binding ofantibodies to proteins, generat-
ing 50,000 Mr fragments on trypsinization. Addition ofrecom-
binant GAD67 did not affect binding, even with sera shown to
be strongly positive for antibodies to GAD67. The results sug-
gest that the 50,000 Mr fragment is derived from the lower Mr
isoform ofGAD, GAD65.
The 37,000 and 40,000 Mr fragments appear to be derived
from a different protein to that generating 50,000 Mr frag-
ments, since we found differences in the expression of the pre-
cursors to these fragments in islets and insulinoma cells. Thus,
precursors of 37,000 and 40,000 Mr fragments were clearly
present in extracts of insulinoma cell lines that lacked precur-
sors of 50,000 Mr fragments, and in normal islets heat shock
treatment reduced synthesis of 50,000 Mr fragments by more
than 90%, but had little effect on synthesis of 37,000 and
40,000 Mr fragments. The results therefore support our sugges-
tion that there is more than one 64,000 Mr autoantigen in
IDDM.
Since GAD67 has also been reported to bind antibodies in
IDDM (8, 9), we investigated whether the 37,000 and 40,000
Mr fragments are derived from this second GAD isoform. Our
findings suggest that GAD67 is not a target for 37k antibodies.
The 37,000 and 40,000 Mr fragments were not recognized by
the sheep antiserum to GAD, indicating either that they are
derived from a non-GAD protein or that trypsin cleavage de-
stroys determinants recognized by this polyclonal antibody.
Neither recombinant GAD65 nor GAD67 competed for autoan-
tibody binding to precursors of 37,000 and 40,000 Mr frag-
ments. No correlation was observed between the ability of anti-
bodies to recognize recombinant GAD67 and the 37,000/
40,000 Mr tryptic fragments and trypsinization ofrecombinant
GAD67 generated 57,000 Mr polypeptides and not 37,000 and
40,000 Mr fragments. Finally, the RIN insulinoma cell line has
been shown to lack expression of both high and low molecular
weight isoforms of GAD (27), and in our experiments neither
GAD immunoreactivity nor GAD mRNA were detectable in
HIT or RIN cells by Western blotting with anti-GAD peptide
antibodies or by Northern blotting with GAD cDNA probes
(data not shown). A GAD enzyme activity was detected in
insulinoma cell lines, but this GAD was not recognized by anti-
bodies in IDDM. Despite the failure to detect GAD65 or GAD67
in RIN and HIT cells, precursors to 37,000 and 40,000 Mr
antigenic fragments were clearly present in these cells. To-
gether, these results provide strong evidence that the 37,000
and 40,000 Mr fragments are derived from proteins distinct
from both GAD65 and GAD67.
The precursors of the 37,000 and 40,000 Mr antigen frag-
ments do appear to be proteins ofMr 64,000. Diffuse bands at
this Mr were immunoprecipitated from islet extracts by GAD-
antibody-negative, 37k-antibody-positive sera. We, and
others, have consistently failed to detect proteins of Mr other
than 64,000 specifically immunoprecipitated by IDDM sera
(28). Two-dimensional electrophoresis of the eluted immune
complexes resolves 64,000 Mr proteins as multiple spots; two
components (a and f3) display charge heterogeneity and have
identical mobility on gels to a and 3 components ofGAD65 (6,
28). A third protein, designated y, with identical Mr to the 3
component, but more negatively charged, has also been re-
ported (29). Analysis of the relationship of the y-component
to 37,000 and 40,000 M, fragments requires specific antibodies
to the protein, which are currently not available.
Diffuse bands ofMr 64,000 were also immunoprecipitated
from extracts ofRIN cells. However, these bands were detected
only when immune complexes were solubilized in the presence
of urea, and the bands were weaker than the 37,000 and 40,000
fragments observed on digestion of immune complexes with
trypsin before electrophoresis (Fig. 5). We have previously ob-
served that only weak bands could be detected by SDS-PAGE
of immunoprecipitates from detergent extracts of islets with
some sera strongly positive for 37k antibodies, and have sug-
gested that 37k antibodies may be directed to determinants
that are hidden on the detergent solubilized protein ( 13 ). How-
ever, the results of the present study show that the native anti-
gen is indeed recognized by 37k antibodies, since precursors of
the 37,000/40,000 Mr fragments were clearly present in im-
munoprecipitates of detergent extracts from RIN cells. The
difficulty in detecting nonproteolyzed antigen appears to be
related to poor solubilization of immune complexes for gel
electrophoresis, rather than poor antibody recognition. Urea, a
strong denaturant, improved solubilization but bands were
weak compared with those seen after proteolysis. Trypsin treat-
ment may remove hydrophobic domains that might impair
solubilization or may assist in dispersing protein aggregates.
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Another potential target for antibodies in diabetes is hsp 65.
However, consistent with an earlier report (17), the islet
64,000 Mr proteins immunoprecipitated by antibodies in dia-
betes migrated at a slightly higher Mr than a 62,000 Mr islet
heat shock protein, and antibodies in sera from diabetic pa-
tients did not specifically recognize heat shock proteins in ex-
tracts of islets. Furthermore, the 37,000:40,000 M, fragments
do not appear to be related to heat shock proteins, since [35S]-
methionine incorporation into 37,000 M, antigenic fragments
was not stimulated by heat shock. Polyclonal antibodies to hsp
65 did not cross-react with 37,000 Mr fragments. These obser-
vations provide further evidence against a role for islet heat
shock proteins as targets for autoantibodies in human IDDM,
either in native form or after proteolysis. The results do not
exclude, however, an association ofIDDM with cellular immu-
nity to heat shock proteins or that autoimmunity to islet anti-
gens might arise through cross-reactivity to epitopes on foreign
heat shock proteins.
With the exception of heat shock proteins, the synthesis of
most islet cell proteins was little affected by heat shock. How-
ever, heat shock treatment caused a dramatic decrease in the
expression of the GAD component of antigen. This finding,
together with the failure of insulinoma cell lines to express the
GAD antigen, indicates that islet GAD has an exquisite sensitiv-
ity to downregulation by a number of factors. Downregulation
of GAD expression in vivo might have important conse-
quences for maintenance of immunological tolerance to the
protein. A reduced expression in early life ofproteins expressed
specifically by pancreatic beta cells has been shown to result in
failure to induce immunological self-tolerance (30). Downreg-
ulation of GAD during early development may result in im-
paired tolerance to the protein and increased susceptibility to
autoimmune responses. Further studies on the regulation of
GAD expression in pancreatic beta cells may provide impor-
tant information relevant to the initiation of autoimmune re-
sponses to the protein in IDDM.
The identification ofGAD65 as an autoantigen in IDDM is
a major advance toward our understanding of autoimmunity
to beta cells in the disease. However, the results of this study
suggest that there is more than one 64,000 Mr protein autoanti-
gen in IDDM and antibodies to 37,000 and 40,000 M, frag-
ments are directed to a protein that is distinct from known
GAD isoforms. The importance of this protein in IDDM is
emphasized by studies in identical twins, where antibodies to
37,000 and 40,000 Mr fragments were found to be more closely
associated with diabetes development than antibodies to GAD
( 31 ). Detection of antibodies to this protein may therefore be
particularly valuable in identifying individuals at risk for dis-
ease. Further characterization of the protein precursor to
37,000 and 40,000 Mr fragments and its relationship to GAD
are critical to our understanding of the respective roles of these
antigens in the immunopathogenesis of IDDM.
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